Reversal of rocuronium with edrophonium during propofol versus sevoflurane anesthesia
- PMID: 11167172
Reversal of rocuronium with edrophonium during propofol versus sevoflurane anesthesia
Abstract
Background: The use of volatile anesthetics for maintenance of anesthesia can enhance the action of non-depolarizing muscle relaxants and interfere with the reversal of neuromuscular blockade. In this study, we studied the antagonism of rocuronium with edrophonium-atropine during propofol- versus sevoflurane-based anesthesia.
Methods: Following induction of anesthesia with propofol (2-2.5 mg kg(-1), i.v.) and fentanyl (1-2 microg kg(-1) i.v.), rocuronium 0.6 mg kg(-1) i.v. was administered to facilitate tracheal intubation. Patients were then randomized to receive either a propofol infusion (100 microg kg(-1) min(-1)) or sevoflurane (1.0%, end-tidal) in combination with nitrous oxide 66% for maintenance of anesthesia. Neuromuscular blockade was monitored using electromyography at the wrist, and reversed with edrophonium 1.0 mg kg(-1) and atropine 0.015 mg kg(-1) when the first twitch hight (T1) of the train-of-four (TOF) stimulation recovered to 25% of the baseline value. Anesthetic maintenance with propofol or sevoflurane was continued following reversal until a TOF ratio of 0.7 was attained.
Results: The clinical duration of action (i.e., time to 25% T1 recovery) was similar during both propofol- (39.3+/-14.6 min) and sevoflurane-based (48.1+/-19.7 min) anesthesia. However, the reversal time from 25% T1 to TOF ratio of 0.7 was significantly longer with sevoflurane [Median 2.8 (range 0.5-18.8) min] compared with propofol [1.5 (0.75-3) min] (P<0.05).
Conclusions: We conclude that the clinical duration of action after a single dose of rocuronium, 0.6 mg kg(-1) i.v., was similar during both propofol- and sevoflurane-based anesthesia. However, the reversal of rocuronium-induced residual blockade was slower and more variable in the presence of sevoflurane.
Similar articles
-
Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.Anesth Analg. 2007 Mar;104(3):563-8. doi: 10.1213/01.ane.0000231829.29177.8e. Anesth Analg. 2007. PMID: 17312209 Clinical Trial.
-
Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.Anesthesiology. 2009 Jul;111(1):30-5. doi: 10.1097/ALN.0b013e3181a51cb0. Anesthesiology. 2009. PMID: 19512873 Clinical Trial.
-
The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.Anesth Analg. 2009 Mar;108(3):846-51. doi: 10.1213/ane.0b013e31818a9932. Anesth Analg. 2009. PMID: 19224792 Clinical Trial.
-
General anesthesia and postoperative pain management in analgesic intolerant patients with/without asthma: is it safe?Allergol Immunopathol (Madr). 2004 Mar-Apr;32(2):64-8. doi: 10.1016/s0301-0546(04)79229-0. Allergol Immunopathol (Madr). 2004. PMID: 15087092 Review.
-
[Update on the practical use of new anesthetic agents].Masui. 2013 Sep;62(9):1088-96. Masui. 2013. PMID: 24063135 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous